Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

The nodal burden in patients with ypN0(i+) was low, and axillary recurrence after ALND omission was rare in patients selected for this approach. These results do not support routine ALND in all patients with ypN0(i+).

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-11-07
DOI
https://doi.org/10.1200/jco.24.01052
Citations
29
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
8.27

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Flávia Vidal Cabero, Eelco de Bree, Neslihan Cabıoğlu, Mariacarla Andreozzi et al.
29 citations
Journal of Clinical Oncology
Breast Cancer Treatment Studies
8.27
article

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Flávia Vidal Cabero, Eelco de Bree, Neslihan Cabıoğlu, Mariacarla Andreozzi, Marios Konstantinos Tasoulis, Susan B. Kesmodel, Johannes Holtschmidt, Oreste ­Gentilini, Hakan Balbaloĝlu, Andraž Perhavec, Stephanie M. Wong, Franziska Fick, Christian Fridolin Singer, Lisa A. Newman, Giacomo Montagna, Nuran Beşe, Christoph Tausch, Florian Fitzal, Alison Laws, Thorsten Kühn, Callie Hlavin, Malgorzata Banys-Paluchowski, Avina Rami, Steven G. Woodward, Jessica Pastoriza, Andrea Veronica Barrio, Susie X. Sun, Sung Gwe Ahn, Güldeniz Karadeniz Çakmak, Denise Vorburger, Jai Min Ryu, M. Vernet-Tomás, Judy C. Boughey, Kerstin Wimmer, Meghan R. Flanagan, Athanasios Tampakis, Mehmet Ali Gülçelik, Christine Deutschmann, Ekaterini Christina Tampaki, Marissa K. Boyle, Marie-Jeanne T. F. D. Vrancken Peeters, Nora Balint‐Lahat, Varadan Sevilimedu, Fabio Corsi, Tae-Kyung Yoo, Jennifer Q. Zhang, Oluwadamilola M. Fayanju, Nina Pislar, Mahmut Muslumanoglu, Francesco Milardi, Mustafa Ümit Uğurlu, Astrid Botty van den Bruele, J.-F. Boileau, Natália Polidorio, Massimo Ferrucci, Annemiek K. E. van Hemert, Valentina Nekljudova, Fredrik Wärnberg, Freya Schnabel, Süleyman Bademler, Daniela Cocco, Martin Heidinger, Glenn Vergauwen, Damiano Gentile, Dawid Murawa, Colin Simonson, Cornelia Leo, Fiorita Poulakaki, Hasan Karanlık, Tehillah S. Menes, Tari A. King, Christopher J. Schwartz, Claire Eden, Ruth S. Eller, Nicola Rocco, Melissa Pilewskie, Monica Morrow, Leonardo Ribeiro Soares, John R. Benson, Fabian Riedel, Edi Brogi, Angelena Crown, William P. Weber, Emilia J. Diego, Henry M. Kuerer, Anne Grabenstetter, Cícero Úrban, Anna Weiss, Daniel Meirelles Barbalho, Austin D. Williams, Justyna Jelinska, Daniele Passeri, Natalia Krawczyk, Emily Siegel, Emanuela Esposito, Mary M. Mrdutt, Maite Goldschmidt, Sherko Kümmel, Julie M Loesch, Nina Ditsch, Tracy-Ann S. Moo, Alexandra Schulz, Cihan Uras, Jörg Heil, Firdos M. Ziauddin
article en
29 citations

Abstract

The nodal burden in patients with ypN0(i+) was low, and axillary recurrence after ALND omission was rare in patients selected for this approach. These results do not support routine ALND in all patients with ypN0(i+).

Journal of Clinical OncologyVol. 43(7)
Ulsan College (KR), Cedars-Sinai Medical Center (US), Brigham and Women's Hospital (US), Albert Einstein College of Medicine (US), Memorial Sloan Kettering Cancer Center (US), Montefiore Medical Center (US), The University of Texas MD Anderson Cancer Center (US), University of Miami (US), Tel Aviv University (IL), University of Basel (CH), Cornell University (US), Sheba Medical Center (IL), Asan Medical Center (KR), Samsung Medical Center (KR), Cambridge University Hospitals NHS Foundation Trust (GB), University Hospital of Basel (CH), The Netherlands Cancer Institute (NL), Zonguldak Bülent Ecevit University (TR), Institute of Oncology Ljubljana (SI), Acıbadem University (TR), University of Ulsan (KR), Presbyterian Hospital (US), Istituto Oncologico Veneto (IT), University Hospital Schleswig-Holstein (DE), Breast Center (CH), Mayo Clinic in Arizona (US), University of Pittsburgh Medical Center (US), University of Pennsylvania Health System (US), Amsterdam University Medical Centers (NL), Sylvester Comprehensive Cancer Center (US), University of Zielona Góra (PL), McGill University (CA), Istanbul University (TR), Marmara University (TR), Sungkyunkwan University (KR), University of Lübeck (DE)
Memorial Sloan-Kettering Cancer Center, National Institutes of Health, National Cancer Institute
Partnerships for the goals
Openalex Percentile: Top 2%
Breast Cancer Treatment Studies
8.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.